3 Tips on Valuations and Exits for Emerging Healthcare Companies
Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…
Posted by
Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…
Posted by
Here at Safeguard Scientifics, we provide capital to growth-stage companies in both the life sciences and technology. It’s important to note, however, that Safeguard provides…
Posted by
Global economic uncertainty, high unemployment, increased government regulation, and issues like healthcare reform are creating a lot of daunting headlines. Those issues are also being blamed…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
It’s the biggest question in our “New Normal” economy—how do you build a successful business during a global recession? Despite the lack of any discernable…
Posted by
This week, we announced details for our Investor Day 2011, scheduled for Tuesday, October, 4 at The Yale Club of New York City. It’s a great…
Posted by
Five books that I’ve read stand out as ideal tutorials for any entrepreneur or CEO. Whether you are launching a business, or looking to elevate…
Posted by
The job of a CFO in a weak economy has become increasingly difficult with each passing quarter, pushing the CFO further into the line of…
Posted by